ARTICLE | Company News
NicOx submits naproxcinod MAA
December 23, 2009 12:41 AM UTC
NicOx S.A. (Euronext:COX) submitted an MAA to EMEA for naproxcinod to relieve the signs and symptoms of osteoarthritis. The cyclooxygenase-inhibiting nitric oxide donator (CINOD) that releases naproxe...